3-(1-((1H-pyrazolo[3,4-b]pyridin-3-yl)Methyl)-5-chloro-1H-indazol-4-yloxy)-5-chlorobenzonitrile

Modify Date: 2025-08-31 19:59:21

3-(1-((1H-pyrazolo[3,4-b]pyridin-3-yl)Methyl)-5-chloro-1H-indazol-4-yloxy)-5-chlorobenzonitrile Structure
3-(1-((1H-pyrazolo[3,4-b]pyridin-3-yl)Methyl)-5-chloro-1H-indazol-4-yloxy)-5-chlorobenzonitrile structure
Common Name 3-(1-((1H-pyrazolo[3,4-b]pyridin-3-yl)Methyl)-5-chloro-1H-indazol-4-yloxy)-5-chlorobenzonitrile
CAS Number 1034474-19-5 Molecular Weight 435.266
Density 1.6±0.1 g/cm3 Boiling Point 656.4±55.0 °C at 760 mmHg
Molecular Formula C21H12Cl2N6O Melting Point N/A
MSDS N/A Flash Point 350.8±31.5 °C

 Use of 3-(1-((1H-pyrazolo[3,4-b]pyridin-3-yl)Methyl)-5-chloro-1H-indazol-4-yloxy)-5-chlorobenzonitrile


MK-6186 is a novel non-nucleoside reverse transcriptase inhibitor with antiviral activity for the study of viral infections.

 Names

Name 3-chloro-5-{[5-chloro-1-(1H-pyrazolo[3,4-b]pyridin-3-ylmethyl)-1H-indazol-4-yl]oxy}benzonitrile

  Biological Activity

Description MK-6186 is a novel non-nucleoside reverse transcriptase inhibitor with antiviral activity for the study of viral infections.
In Vitro MK-6186 showed FCs of <10 against EFV or etravirine (ETR) and the mutant viruses containing mutations selected by EFV or ETR were sensitive to MK-6186 (FCs of <10).[1]
References 1. Lu M, et al. Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2012 Jun;56(6):3324-35.

 Chemical & Physical Properties

Density 1.6±0.1 g/cm3
Boiling Point 656.4±55.0 °C at 760 mmHg
Molecular Formula C21H12Cl2N6O
Molecular Weight 435.266
Flash Point 350.8±31.5 °C
Exact Mass 434.044952
PSA 92.41000
LogP 4.86
Vapour Pressure 0.0±2.0 mmHg at 25°C
Index of Refraction 1.763
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.